Add-on Acquisition • Life Science

New England Biolabs Acquires Fluorogenics

On May 10, 2021, New England Biolabs acquired life science company Fluorogenics

Acquisition Context
  • This is New England Biolabs’ 1st transaction in the Life Science sector.
  • This is New England Biolabs’ 1st transaction in the United Kingdom.

Explore All 3111 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date May 10, 2021
Target Fluorogenics
Sector Life Science
Buyer(s) New England Biolabs
Deal Type Add-on Acquisition

Target Company

Fluorogenics

Wiltshire, United Kingdom
Fluorogenics is a lyophilization R&D service company. Fluorogenics' brings extensive technical expertise to cutting-edge sample-to-result integrated analyzers and real-time PCR lyophilized reagents. Fluorogenic serves a growing global market with leading performance ambient stable, designed-for-manufacture solutions Fluorogenics was founded in 2011 and is based in Wiltshire, United Kingdom.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

New England Biolabs

Ipswich, Massachusetts, United States

Category Company
Founded 1974
Sector Life Science
DESCRIPTION

New England Biolabs is a provider of life science reagents discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next-generation sequencing, synthetic biology, glycobiology, epigenetics, and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development. New England Biolabs was founded in 1974 and is based in Ipswich, Massachusetts.


Deal Context for Buyer #
Overall 1 of 1
Sector: Life Science 1 of 1
Type: Add-on Acquisition 1 of 1
Country: United Kingdom 1 of 1
Year: 2021 1 of 1